Aspirin trial extended

A landmark study tracking the effects of low-dose aspirin on the health of older people has been extended for five years Researchers at Monash University and the US-based Berman Center for Outcomes and Clinical Research, part of the Hennepin Healthcare Research Institute, are expanding on the landmark aspirin trial, ASPREE, with a five-year follow up